| Medical and Health Sciences | 2021-2025 | 930 | BE 17 | 99.78 |
| Obstetrics and Gynecology | Lifetime | 22 | BE 2 | 99.81 |
| Reproductive Medicine | Lifetime | 107 | BE 3 | 99.40 |
| Oncology | Lifetime | 351 | BE 6 | 99.41 |
| Pediatrics, Perinatology and Child Health | Lifetime | 806 | BE 8 | 97.33 |
| Oncology | 2021-2025 | 139 | BE 4 | 99.01 |
| Obstetrics and Gynecology | 2021-2025 | 68 | BE 3 | 98.48 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 206 | BE 2 | 96.14 |
| Reproductive Medicine | 2021-2025 | 204 | BE 8 | 90.37 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 10 | BE 2 | 99.82 |
| Ovarian cancer diagnosis and treatment | Lifetime | 34 | BE 2 | 99.70 |
| Uterine Myomas and Treatments | Lifetime | 17 | BE 2 | 99.76 |
| Multiple and Secondary Primary Cancers | Lifetime | 30 | BE 1 | 99.53 |
| Cancer Risks and Factors | Lifetime | 67 | BE 1 | 99.41 |
| Endometriosis Research and Treatment | Lifetime | 130 | BE 8 | 98.96 |
| Sarcoma Diagnosis and Treatment | Lifetime | 259 | BE 3 | 98.89 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 220 | BE 4 | 98.75 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 154 | BE 6 | 97.86 |
| Cervical Cancer and HPV Research | Lifetime | 698 | BE 10 | 97.05 |
| Renal and related cancers | Lifetime | 775 | BE 11 | 96.66 |
| Gestational Trophoblastic Disease Studies | Lifetime | 206 | BE 2 | 93.33 |
| Gynecological conditions and treatments | Lifetime | 680 | BE 20 | 92.92 |
| Cancer-related cognitive impairment studies | Lifetime | 549 | BE 5 | 89.94 |
| Beetle Biology and Toxicology Studies | Lifetime | 315 | BE 2 | 68.27 |
| Cancer Risks and Factors | 2021-2025 | 7 | BE 1 | 99.23 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 45 | BE 2 | 99.07 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 31 | BE 1 | 95.71 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 105 | BE 3 | 98.13 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 146 | BE 1 | 97.03 |
| Prenatal Screening and Diagnostics | 2021-2025 | 95 | BE 5 | 96.18 |
| Cervical Cancer and HPV Research | 2021-2025 | 326 | BE 4 | 93.56 |
| Global Cancer Incidence and Screening | 2021-2025 | 573 | BE 4 | 91.76 |
| Renal and related cancers | 2021-2025 | 413 | BE 5 | 89.24 |
| Estrogen and related hormone effects | 2021-2025 | 453 | BE 12 | 80.72 |
| Family Support in Illness | 2021-2025 | 853 | BE 14 | 76.65 |
